Acta Pharmaceutica Sinica B(2021年01期)
药学学报(英文版)

目 录

• Calls for Papers
• Acta Pharmaceutica Sinica B 2019 Impact Factor 7.097
• Information for Authors
• Reviews
• Angiotensin-converting enzyme 2(ACE2):SARS-CoV-2 receptor and RAS...
• Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
• Selective inhibition of CDK4/6: A safe and effective strategy for...
• Recent advances in drug delivery systems for targeting cancer ste...
• Original articles
• Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenua...
• SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induce...
• The antimicrobial peptide YD attenuates inflammation via miR-155 ...
• Scutellarin inhibits caspase-11 activation and pyroptosis in macr...
• VEGF-B antibody and interleukin-22 fusion protein ameliorates dia...
• Chrysin serves as a novel inhibitor of DGKα/FAK interaction to s...
• Design, synthesis, and biological evaluation of quinazolin-4(3H)-...
• Discovery of novel diarylamides as orally active diuretics target...
• Discovery of thiosemicarbazone derivatives as effective New Delhi...
• Identifying potential anti-COVID-19 pharmacological components of...
• Crystal structure of SARS-CoV-2 papain-like protease
• A smart dual-drug nanosystem based on coassembly of plant and foo...
• A facile and universal method to achieve liposomal remote loading...
• Photothermal/matrix metalloproteinase-2 dual-responsive gelatin n...
• A pentapeptide enabled AL3810 liposome-based glioma-targeted ther...
• Policy forum
• Botanical drug clinical trial: Common issues and future options
• Letter to the editor
• Letter to the editor: Neutralizing antibodies for the treatment o...